A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
2020-07-04
عنوان الدراسة
A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes.
داعم الدراسة
GW
دواء الدراسة
Cannabidiol & Tetrahydrocannabivarin
رقم بروتوكول الدراسة
GWZMD1190
حالة الدراسة
Rejected
موقع الدراسة
N\A
مرحلة الدراسة
2a
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。